IHS (IHS) Reaffirms FY15 Outlook

IHS (NYSE: IHS) will publicly reaffirm its earnings guidance during its previously announced Investor Day presentation to be made today in New York City.

For the year ending November 30, 2015, IHS expects:

• Revenue at the mid-point of the range of $2.30 billion to $2.34 billion, including the low end of 5-6 percent subscription organic growth, negative non-subscription organic growth, and total organic growth of 1-2 percent;
• Adjusted EBITDA toward the high end of the range of $725 million to $740 million; and
• Adjusted EPS toward the high end of the range of $5.80 to $6.00 per diluted share.

The above outlook assumes no further currency movements, acquisitions, divestitures, pension mark-to-market adjustments or unanticipated events. See discussion of non-GAAP financial measures at the end of this release.

You May Also Be Interested In

• SpaceX sets date for maiden earnings report: Why August 4 is make-or-break
• Farmers & Merchants Bancorp (FMCB) Reports Q2 EPS of $36.39
• Cardinal Health to acquire AdaptHealth diabetes unit and Strive Medical for $360M